Just a day after introducing its plans for overhauling the EU pharmaceutical legislation, the European Commission has launched another set of major proposals, this time including a new EU-level system for issuing compulsory licences for crisis-related products such as medicines.
EU-Wide Compulsory Licensing Plan Draws R&D Industry Ire
The European Commission says its proposals on EU-level compulsory licensing and a unitary supplementary protection certificate will create a more efficient and future-proof framework for intellectual property rights.
